Astragaloside IV inhibits platelet-derived growth factor-BB-stimulated proliferation and migration of vascular smooth muscle cells via the inhibition of p38 MAPK signaling

Experimental and Therapeutic Medicine

Volumn 8, Issue 4, 2014, Pages 1253-1258

  Chen, Zhuo ^a   Cai, Ying ^a   Zhang, Wenliang ^a   Liu, Xinzhou ^a   Liu, Suixin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Astragaloside IV; Migration; Platelet derived growth factor; Proliferation; Vascular smooth muscle cell

Indexed keywords

ASTRAGALOSIDE IV; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PLATELET DERIVED GROWTH FACTOR BB;

ANTIMIGRATORY ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CELL CULTURE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

EID: 84906498793     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1905     Document Type: Article

References (30)

1. Ren S, Zhang H, Mu Y, Sun M and Liu P: Pharmacological effects of Astragaloside IV: a literature review. J Tradit Chin Med 33: 413-416, 2013.
2. Zhang Y, Hu G, Li S, et al: Pro-angiogenic activity of astragaloside IV in HUVECs in vitro and zebrafish in vivo. Mol Med Rep 5: 805-811, 2012.
3. Zhang L, Liu Q, Lu L, Zhao X, Gao X and Wang Y: Astragaloside IV stimulates angiogenesis and increases hypoxia-inducible factor-1α accumulation via phosphatidylinositol 3-kinase/Akt pathway. J Pharmacol Exp Ther 338: 485-491, 2011.
4. Wang SG, Xu Y, Chen JD, Yang CH and Chen XH: Astragaloside IV stimulates angiogenesis and increases nitric oxide accumulation via JAK2/STAT3 and ERK1/2 pathway. Molecules 18: 12809-12819, 2013.
5. Choe N, Kwon JS, Kim JR, et al: The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia. Atherosclerosis 229: 348-355, 2013.
6. Dong S, Xiong W, Yuan J, Li J, Liu J and Xu X: MiRNA-146a regulates the maturation and differentiation of vascular smooth muscle cells by targeting NF-kappaB expression. Mol Med Rep 8: 407-412, 2013.
7. Lacolley P, Regnault V, Nicoletti A, Li Z and Michel JB: The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc Res 95: 194-204, 2012.
8. Yang HM, Kim BK, Kim JY, et al: PPARγ modulates vascular smooth muscle cell phenotype via a protein kinase G-dependent pathway and reduces neointimal hyperplasia after vascular injury. Exp Mol Med 45: e65, 2013.
9. Chen J, Xu L and Huang C: DHEA inhibits vascular remodeling following arterial injury: a possible role in suppression of inflammation and oxidative stress derived from vascular smooth muscle cells. Mol Cell Biochem 388: 75-84, 2014.
10. Pi Y, Zhang LL, Li BH, et al: Inhibition of reactive oxygen species generation attenuates TLR4-mediated proinflammatory and proliferative phenotype of vascular smooth muscle cells. Lab Invest 93: 880-887, 2013.
11. Yoo SH, Lim Y, Kim SJ, et al: Sulforaphane inhibits PDGF-induced proliferation of rat aortic vascular smooth muscle cell by up-regulation of p53 leading to G1/S cell cycle arrest. Vascul Pharmacol 59: 44-51, 2013.
12. Donovan J, Abraham D and Norman J: Platelet-derived growth factor signaling in mesenchymal cells. Front Biosci (Landmark Ed) 18: 106-119, 2013.
13. Yang XP, Pei ZH and Ren J: Making up or breaking up: the tortuous role of platelet-derived growth factor in vascular ageing. Clin Exp Pharmacol Physiol 36: 739-747, 2009.
14. Martin-Garrido A, Williams HC, Lee M, et al: Transforming growth factor β inhibits platelet derived growth factor-induced vascular smooth muscle cell proliferation via Akt-independent, Smad-mediated cyclin D1 downregulation. PLoS One 8: e79657, 2013.
15. Park ES, Kang SI, Yoo KD, et al: Camptothecin inhibits platelet-derived growth factor-BB-induced proliferation of rat aortic vascular smooth muscle cells through inhibition of PI3K/Akt signaling pathway. Exp Cell Res 319: 982-991, 2013.
16. Li FL, Li X, Wang YF, et al: Astragaloside IV downregulates β-catenin in rat keratinocytes to counter LiCl-induced inhibition of proliferation and migration. Evid Based Complement Alternat Med 2012: 956107, 2012.
17. Branchetti E, Poggio P, Sainger R, et al: Oxidative stress modulates vascular smooth muscle cell phenotype via CTGF in thoracic aortic aneurysm. Cardiovasc Res 100: 316-324, 2013.
18. van der Veer EP, de Bruin RG, Kraaijeveld AO, et al: Quaking, an RNA-binding protein, is a critical regulator of vascular smooth muscle cell phenotype. Circ Res 113: 1065-1075, 2013.
19. Gan J, Li P, Wang Z, et al: Rosuvastatin suppresses platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferation and migration via the MAPK signaling pathway. Exp Ther Med 6: 899-903, 2013.
20. Salabei JK, Cummins TD, Singh M, Jones SP, Bhatnagar A and Hill BG: PDGF-mediated autophagy regulates vascular smooth muscle cell phenotype and resistance to oxidative stress. Biochem J 451: 375-388, 2013.
21. Xiao Q, Zhang F, Grassia G, et al: Matrix metalloproteinase-8 promotes vascular smooth muscle cell proliferation and neointima formation. Arterioscler Thromb Vasc Biol 34: 90-98, 2014.
22. Karki R, Kim SB and Kim DW: Magnolol inhibits migration of vascular smooth muscle cells via cytoskeletal remodeling pathway to attenuate neointima formation. Exp Cell Res 319: 3238-3250, 2013.
23. Guo J, Li L, Wu YJ, et al: Inhibitory effects of Brazilin on the vascular smooth muscle cell proliferation and migration induced by PDGF-BB. Am J Chin Med 41: 1283-1296, 2013.
24. Risinger GM, Jr, Updike DL, Bullen EC, Tomasek JJ and Howard EW: TGF-beta suppresses the upregulation of MMP-2 by vascular smooth muscle cells in response to PDGF-BB. Am J Physiol Cell Physiol 298: C191-C201, 2010.
25. Karakiulakis G, Papakonstantinou E, Aletras AJ, Tamm M and Roth M: Cell type-specific effect of hypoxia and platelet-derived growth factor-BB on extracellular matrix turnover and its consequences for lung remodeling. J Biol Chem 282: 908-915, 2007.
26. Han SG, Newsome B and Hennig B: Titanium dioxide nanoparticles increase inflammatory responses in vascular endothelial cells. Toxicology 306: 1-8, 2013.
27. Kanaji N, Nelson A, Wang X, et al: Differential roles of JNK, ERK1/2, and p38 mitogen-activated protein kinases on endothelial cell tissue repair functions in response to tumor necrosis factor-α. J Vasc Res 50: 145-156, 2013.
28. Jiang F, Jiang R, Zhu X, Zhang X and Zhan Z: Genipin inhibits TNF-α-induced vascular smooth muscle cell proliferation and migration via induction of HO-1. PLoS One 8: e74826, 2013.
29. Cheng C, Haasdijk RA, Tempel D, et al: PDGF-induced migration of vascular smooth muscle cells is inhibited by heme oxygenase-1 via VEGFR2 upregulation and subsequent assembly of inactive VEGFR2/PDGFRβ heterodimers. Arterioscler Thromb Vasc Biol 32: 1289-1298, 2012.
30. Hu Y, Cheng P, Ma JC, Xue YX and Liu YH: Platelet-derived growth factor BB mediates the glioma-induced migration of bone marrow-derived mesenchymal stem cells by promoting the expression of vascular cell adhesion molecule-1 through the PI3K, P38 MAPK and NF-κB pathways. Oncol Rep 30: 2755-2764, 2013.